Next, we found significantly higher DVL2 protein expression in the same cohort in different molecular subtypes of breast cancer: Luminal (n = 64), HER2+ (n = 10), TNBC (n = 16) compared to normal breast tissue (n = 18) (p < 0.0001). Here, DVL2 is linked to breast carcinoma.